<i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children’s Oncology Group P9407 trial study-Reference-Cited by-同舟云学术

<i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children’s Oncology Group P9407 trial study

Published:2023-03-02 Issue:10 Volume:108 Page:2865-2871
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Robinson Blaine W.,Kairalla John A.,Devidas Meenakshi,Carroll Andrew J.,Harvey Richard C.,Heerema Nyla A.,Willman Cheryl L.,Ball Amanda R.,Woods Elliot C.,Ballantyne Nancy C.,Urtishak Karen A.,Behm Frederick G.,Reaman Gregory H.,Hilden Joanne M.,Camitta Bruce M.,Winick Naomi J.,Pullen Jeanette,Carroll William L.,Hunger Stephen P.,Dreyer ZoAnn E.,Felix Carolyn A.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference18 articles.

1. Hilden JM, Dinndorf PA, Meerbaum SO. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006; 108(2):441-451.

2. Pieters R, Schrappe M, De Lorenzo P. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007; 370(9583):240-250.

3. Dreyer ZE, Hilden JM, Jones TL. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3). Pediatr Blood Cancer. 2015; 62(3):419-426.

4. Pieters R, De Lorenzo P, Ancliffe P. Outcome of infants younger than 1 Year with acute lymphoblastic leukemia treated with the Interfant-06 Protocol: results from an international phase III randomized study. J Clin Oncol. 2019; 37(25):2246-2256.

5. Brown PA, Kairalla JA, Hilden JM. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631. Leukemia. 2021; 35(5):1279-1290.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress;Cold Spring Harbor Perspectives in Medicine;2024-03-11